Pre-Solicitation Conference Questionnaire.xlsx

XLSX spreadsheet 17 KB Posted

Attached to
REQUEST FOR INFORMATION (RFI): Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)
Solicitation number
7571MN26R00052
Issued by
Not on record

About this file

This is a Pre-Solicitation Conference Questionnaire designed to collect market research and acquisition planning feedback from industry vendors regarding a federal contracting opportunity.

The Department of Health and Human Services, Office of Mission Acquisitions Solutions (OMAS), is seeking candid industry feedback on a previous Request for Information (RFI) for Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS) procurement (Solicitation Numbers 7571MN26R00052 and 7571MN26R00026). The Government experienced lower-than-anticipated industry response and proposal quality and is engaging vendors to identify factors affecting participation. Completed questionnaires must be submitted by December 1, 2026, at 12:00 p.m. ET to Contract Specialist Chaunda Stewart (Chaunda.Stewart@hhs.gov) or Contracting Officer Lynn Tantardini (Lynn.Tantardini@hhs.gov). The questionnaire covers forty topics organized into nine sections: presolicitation factors, technical requirements clarity and feasibility, pricing structure and commercial viability, evaluation criteria and proposal instructions, competition and industry perspectives, vendor capabilities for Just-in-Time medications/vaccines/medical supplies delivery across CONUS and OCONUS locations, subcontracting and teaming arrangements, acquisition strategy recommendations including NAICS codes, supply chain resilience strategies, ordering system capabilities, and recommendations for future solicitations. Responses are voluntary, non-binding, and should exclude proprietary or sensitive information. A virtual Pre-Solicitation Conference is scheduled for December 7, 2026, from 10:00 a.m. to 11:30 a.m. ET via Microsoft Teams.

View the file

Other files

File Type Posted
DRAFT SolicitationMVMS V7.2.pdf PDF
RFI Presolicitation Conference Notice.docx DOCX document
Final Draft Solicitation Conference Questions.xlsx XLSX spreadsheet
Agenda-Presolicitation Conference.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Submission Instructions

Submission Instructions
Please submit the completed questionnaire to:

Government Points of Contact: Contract Specialist, Chaunda Stewart at Chaunda.Stewart@hhs.gov Contracting Officer, Lynn Tantardini at Lynn.Tantardini@hhs.gov

Deadline: Questionnaire due Tuesday, December 1, 2026, by 12:00 p.m. ET. (Before the Pre-Solicitation Conference)

Note: Responses are voluntary and are being collected for market research and acquisition planning purposes. Do not include proprietary, confidential, classified, or other sensitive information in your responses. Responses do not constitute a commitment by the Government to issue a solicitation or award a contract.

Note: Companies choosing to complete the questionnaire should complete TAB 2 "Company Info" and TAB 3 "Questionnaire"

Note: Please include the company name in the naming of the excel file when sending the questionnaire to the Government Points of Contact.

Company Info

Agency & Company InformationCompany Responses
Company Name
Company Address
Point of Contact
Point of Contact Title
Email Address
Unique Entity Identifier (UEI)
Business Size
Socioeconomic Status (if applicable)
Years of Experience Providing Similar Services

Questionnaire

Presolicitation QuestionsCompany Response
1Did your company review the previous solicitation?
2Did your company consider submitting a proposal?
3Did your company submit a proposal?
4If your company did not submit a proposal, what was the primary reason?
Technical RequirementsCompany Response
5Were the technical requirements clearly defined?
6Were the requirements reasonable and achievable?
7Were any requirements unnecessarily restrictive or overly complicated?
8Were the performance expectations, deliverables, and timelines realistic?
9What changes would you recommend to improve the Statement of Work or Performance Work Statement?
Pricing StructureCompany Response
10Was the anticipated contract value sufficient to perform the required work?
11Were the pricing instructions clear?
12

Did the pricing structure create any barriers to participation? If yes, please explain.

13Were the contract type and period of performance appropriate?
14What changes would make the opportunity more commercially viable?
Eval and ProposalCompany Response
15Were the evaluation factors and criteria clearly explained?
16Were the proposal submission instructions reasonable?
17Were the experience, staffing, certification, or past performance requirements appropriate?
18Were there any administrative or documentation requirements that discouraged participation? If yes, please explain.
Competition and IndustryCompany Response
19What changes would encourage your company to participate in a future solicitation for this requirement?
20Would your company consider submitting a proposal if the Government revised and reissued the requirement?
21Would allowing subcontracting or teaming arrangements increase your company's interest?
22Would changes to the contract structure, scope, or performance requirements increase competition?
23Are there other companies, business categories, or industry segments that the Government should consider engaging?
CapabilitiesCompany Response
24Does your company have the capability and resources to perform all services identified in the previously posted solicitation and associated Performance Work Statement (PWS)? Please identify any limitations, gaps, or areas where additional resources or support would be required.
25Does your company currently provide Just-in-Time (JIT) medications, vaccines, and/or medical supplies? If yes, please describe your experience, capabilities, distribution model, and the types of products typically provided.
26Does your company have the capability to deliver products to multiple locations across various states and U.S. territories, including both Continental United States (CONUS) and Outside Continental United States (OCONUS) locations? Please identify any geographic limitations or logistical challenges.
27Does your company have the capability to meet the requested period of performance identified in the previously posted solicitation? Please identify any concerns regarding the proposed schedule, transition requirements, or implementation timeline.
SubcontractingCompany Response
28Would your company anticipate subcontracting any portion of this requirement to other firms? If yes, please identify the anticipated percentage of work to be subcontracted, the specific services or requirements that would be subcontracted, and whether subcontracting would be necessary to meet the Government's requirements.
29Would your company anticipate the need to establish a joint venture, contractor team arrangement, or other partnership involving multiple companies to successfully fulfil this requirement? Please explain.
Acquisition StrategyCompany Response
30What North American Industry Classification System (NAICS) code(s) would your company recommend as most appropriate for this requirement? Please provide the rationale for your recommendation, including any considerations related to the primary nature and scope of the work.
31Based on your review of the previously posted solicitation, what aspects of the Performance Work Statement (PWS), if any, do you consider unfeasible, overly restrictive, unclear, or otherwise problematic for industry? Please identify specific sections and provide recommendations for improvement.
32Were any of the Phase 1 evaluation criteria problematic, unclear, or potentially restrictive to industry participation? If so, please identify the specific criteria and recommend alternative approaches or revisions.
Supply ChainCompany Response
33What processes or strategies would your company implement to minimize the impact of product delays, supply chain disruptions, or backordered medications, vaccines, and medical supplies? Please describe your approach to identifying alternative products, maintaining inventory availability, communicating delays, and ensuring continuity of service.
34What additional fees or charges does your company typically assess in connection with purchases under requirements of this nature? Examples may include restocking fees, replacement costs, shipping and expedited shipping charges, special handling or cold-chain transportation fees, cancellation fees, and other administrative or service-related charges. Please identify applicable fees, the circumstances under which each fee would be assessed, and whether any fees may be waived.
35Do you have any concerns regarding the Government's requirement for medications, vaccines, and/or medical supplies to comply with the Buy American Act (BAA) and/or Trade Agreements Act (TAA), as applicable? Please identify any potential sourcing, availability, cost, or supply chain challenges associated with meeting these requirements.
Ordering SystemCompany Response
36Does your company provide an accessible electronic ordering portal or other ordering platform to support the ordering and fulfillment of medications, vaccines, and medical supplies? If yes, please indicate which capabilities are available and provide additional details.
Recommendations and FutureCompany Response
37What are the three most important changes the Government should consider before issuing a future solicitation?
38Are there any additional comments or recommendations you would like the Government to consider?
39Would your company like to receive notifications regarding future market research or solicitation opportunities related to this requirement?
40Would your company be interested in participating in additional industry engagement activities?

File details come from the government source that posted it. Updated .